These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 15653962)
1. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study. Hering D; Piper C; Bergemann R; Hillenbach C; Dahm M; Huth C; Horstkotte D Chest; 2005 Jan; 127(1):53-9. PubMed ID: 15653962 [TBL] [Abstract][Full Text] [Related]
2. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. Horstkotte D; Schulte HD; Bircks W; Strauer BE J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1136-45. PubMed ID: 8159036 [TBL] [Abstract][Full Text] [Related]
3. Thrombo-embolic and bleeding complications in patients with mechanical valve replacements--a prospective observational study. Schapkaitz E; Jacobson BF; Becker P; Conway G S Afr Med J; 2006 Aug; 96(8):710-3. PubMed ID: 17019493 [TBL] [Abstract][Full Text] [Related]
5. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. Horstkotte D; Schulte H; Bircks W; Strauer B J Heart Valve Dis; 1993 May; 2(3):291-301. PubMed ID: 8269122 [TBL] [Abstract][Full Text] [Related]
7. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis. Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesis. Emery RW; Krogh CC; McAdams S; Emery AM; Holter AR J Heart Valve Dis; 2010 Jul; 19(4):473-84. PubMed ID: 20845896 [TBL] [Abstract][Full Text] [Related]
9. Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy. Van Nooten GJ; Caes F; François K; Van Bellleghem Y; Bové T; Vandenplas G; Taeymans Y J Heart Valve Dis; 2012 Jan; 21(1):88-98. PubMed ID: 22474748 [TBL] [Abstract][Full Text] [Related]
11. [The target value of anticoagulation intensity for Chinese patients after mechanical heart valve replacement]. Dong L; Xu JP; Zhu D Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(30):2314-2319. PubMed ID: 37574828 [No Abstract] [Full Text] [Related]
17. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852 [TBL] [Abstract][Full Text] [Related]
19. Long-term results of valve replacement with the St. Jude Medical prosthesis. Baudet EM; Puel V; McBride JT; Grimaud JP; Roques F; Clerc F; Roques X; Laborde N J Thorac Cardiovasc Surg; 1995 May; 109(5):858-70. PubMed ID: 7739245 [TBL] [Abstract][Full Text] [Related]
20. Bileaflet mechanical prostheses for aortic valve replacement in patients younger than 65 years and 65 years of age or older: major thromboembolic and hemorrhagic complications. Jamieson WR; Miyagishima RT; Grunkemeier GL; Germann E; Henderson C; Lichtenstein SV; Ling H; Munro AI Can J Surg; 1999 Feb; 42(1):27-36. PubMed ID: 10071585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]